Magic mushroom compound tested for dual mental health conditions

This small, completed study from the University of Chicago explored whether a single dose of psilocybin, the active compound in 'magic mushrooms,' could safely reduce symptoms in adults diagnosed with both major depression and borderline personality disorder. Nine participants received the dose and were monitored to see if their symptoms improved over four weeks. The goal was to gather early evidence on safety and whether this approach could help ease the burden of these challenging conditions.